Akatsuki AET Fund returned for a series A round led by Tencent that will help the online education platform with hiring, technology development and additional content.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Saint Louis University spinout BioIntervene will use the capital to fund phase 1 trials for its non-addictive painkillers later this year.

Gradient Ventures contributed to a $23m round for the Intel-backed visual collaboration software provider, which plans to double its size by the end of this year.

AbbVie Ventures took a board seat through its contribution to the round, closed as the inflammatory disease therapy developer emerged from stealth.

Merck Group spinoff iOnctura will put the $18.7m it raised in the M Ventures-backed round into a clinical trial for its solid tumour therapy.

The inflammatory disease therapy developer emerged from stealth to commercialise research from several Max Planck institutes and LDC.

SoftBank led a series A round for the robotic waiter developer that included fellow corporate investors Line Ventures, Lotte Group, Smilegate and DSC.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.